Although pre-treatment of FAP-CAR T cells followed by anti-PD-1 therapy showed enhanced inhibition of PDAC tumor growth, the overall survival was only modestly improved, thus warranting investigation of other combination therapies. This evidence concerns the gene FAP and neoplasm.